BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2533147)

  • 1. Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors.
    Crook D; Gardner R; Worthington M; Nolan J; Stevenson JC; Shaw RW
    Horm Res; 1989; 32 Suppl 1():157-60. PubMed ID: 2533147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis.
    Dlugi AM; Rufo S; D'Amico JF; Seibel MM
    Fertil Steril; 1988 May; 49(5):913-6. PubMed ID: 3129319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women.
    Fåhraeus L; Larsson-Cohn U; Ljungberg S; Wallentin L
    Fertil Steril; 1984 Jul; 42(1):52-7. PubMed ID: 6724013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study.
    Dmowski WP; Radwanska E; Binor Z; Tummon I; Pepping P
    Fertil Steril; 1989 Mar; 51(3):395-400. PubMed ID: 2493400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of plasma lipids and lipoprotein levels during danazol treatment for endometriosis.
    Schweppe KW; Assmann G
    Horm Metab Res; 1984 Nov; 16(11):593-7. PubMed ID: 6510890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis.
    Välimäki M; Nilsson CG; Roine R; Ylikorkala O
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1097-103. PubMed ID: 2531153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Goserelin versus danazol in the treatment of endometriosis.
    Giorgino FL; Cetera C; de Laurentiis G
    Clin Exp Obstet Gynecol; 1991; 18(2):127-31. PubMed ID: 1833094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the skeletal effects of goserelin and danazol in premenopausal women with endometriosis.
    Stevenson JC; Lees B; Gardner R; Shaw RW
    Horm Res; 1989; 32 Suppl 1():161-3; discussion 164. PubMed ID: 2533148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol.
    Burry KA; Patton PE; Illingworth DR
    Am J Obstet Gynecol; 1989 Jun; 160(6):1454-9; discussion 1459-61. PubMed ID: 2525337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of danazol in the management of endometriosis.
    Young MD; Blackmore WP
    J Int Med Res; 1977; 5 Suppl 3():86-91. PubMed ID: 913886
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol.
    Lemay A; Brideau NA; Forest JC; Dodin S; Maheux R
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):305-10. PubMed ID: 1836425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group.
    Rock JA; Truglia JA; Caplan RJ
    Obstet Gynecol; 1993 Aug; 82(2):198-205. PubMed ID: 8336864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine effects of danazol in the treatment of endometriosis.
    Bevan JR; Dowsett M; Jeffcoate SL
    Br J Obstet Gynaecol; 1984 Feb; 91(2):160-6. PubMed ID: 6538094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosis.
    Luciano AA; Hauser KS; Chapler FK; Davis WA; Wallace RB
    Am J Obstet Gynecol; 1983 Feb; 145(4):422-6. PubMed ID: 6824034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol, high density lipoprotein and danazol.
    Allen JK; Fraser IS
    J Clin Endocrinol Metab; 1981 Jul; 53(1):149-52. PubMed ID: 7240372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lipoproteins during and after danazol treatment.
    Fåhraeus L; Larsson-Cohn U; Ljungberg S; Wallentin L
    Acta Obstet Gynecol Scand Suppl; 1984; 123():133-5. PubMed ID: 6594004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis.
    Maouris P; Dowsett M; Rose G; Edmonds DK; Rothwell C; Robertson WR
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):539-46. PubMed ID: 2146047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group.
    Dawood MY; Spellacy WN; Dmowski WP; Gambrell RD; Greenblatt RB; Girard Y; Lemay A; Mishell DR; Nagamani M; Pepperell RJ
    Prog Clin Biol Res; 1990; 323():253-67. PubMed ID: 2106142
    [No Abstract]   [Full Text] [Related]  

  • 19. Danazol in endometriosis.
    Ratnapala SR
    Ceylon Med J; 1982 Mar; 27(1):42-5. PubMed ID: 7151242
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of pelvic endometriosis with danazol].
    Garcea N; Siccardi P; Caruso A; Campo S
    Minerva Ginecol; 1980 Nov; 32(11):1049-56. PubMed ID: 7219815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.